e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Host-pathogen interaction in respiratory virus infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nitric oxide gas: a potential respiratory antiviral
C. Miller, A. Schaefer, B. Perry, N. Cook (Tofield, Lacombe, Canada)
Source:
Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Session:
Host-pathogen interaction in respiratory virus infections
Session type:
Oral Presentation
Number:
1700
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Miller, A. Schaefer, B. Perry, N. Cook (Tofield, Lacombe, Canada). Nitric oxide gas: a potential respiratory antiviral. Eur Respir J 2005; 26: Suppl. 49, 1700
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Exhaled nitric oxide in reactive pulmonary hypertenzion
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
The effect of bronchodilation and spirometry on exhaled nitric oxide
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
Nitric oxide in primary ciliary dyskinesia},
Source: Eur Respir J 2012; 40: 1024-1032
Year: 2012
Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
The effect of ambient nitric oxide on exhaled nitric oxide measurement in children
Source: Eur Respir J 2002; 20: Suppl. 38, 141s
Year: 2002
The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Potential for personalised application of inhaled nitric oxide in Covid-19 pneumonia
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021
Longitudinal variability of nasal nitric oxide measurements during winter
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters
Source: Eur Respir J 2006; 28: 339-345
Year: 2006
Fractional exhaled nitric oxide during acute viral bronchiolitis and future asthma at the age of four years
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Effective patient selection for PCD diagnostics; the PICADAR score with nasal nitric oxide
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016
Exhaled nitric oxide in mustard airway disease
Source: International Congress 2018 – Occupational and environmental lung diseases: influence on the airway and interstitium
Year: 2018
Data processing for steady-state models of multiple flow exhaled nitric oxide
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016
Exhaled nitric oxide (NO) in patients with chronic cough
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept